1. Home
  2. FOSL vs RCKT Comparison

FOSL vs RCKT Comparison

Compare FOSL & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fossil Group Inc.

FOSL

Fossil Group Inc.

SELL

Current Price

$7.16

Market Cap

418.7M

ML Signal

SELL

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

BUY

Current Price

$2.31

Market Cap

394.2M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
FOSL
RCKT
Founded
1984
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
418.7M
394.2M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
FOSL
RCKT
Price
$7.16
$2.31
Analyst Decision
Strong Buy
Buy
Analyst Count
4
14
Target Price
★ $9.25
$8.58
AVG Volume (30 Days)
733.7K
★ 2.1M
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
25.26
★ 26.37
EPS
N/A
★ 0.66
Revenue
★ $1,004,406,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.39
$915.60
P/E Ratio
★ N/A
$3.76
Revenue Growth
N/A
★ N/A
52 Week Low
$1.70
$2.42
52 Week High
$7.33
$5.45

Technical Indicators

Market Signals
Indicator
FOSL
RCKT
Relative Strength Index (RSI) 69.18 26.79
Support Level $3.74 N/A
Resistance Level $7.33 $4.02
Average True Range (ATR) 0.38 0.18
MACD 0.05 -0.02
Stochastic Oscillator 88.98 2.61

Price Performance

Historical Comparison
FOSL
RCKT

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation, and distribution company in consumer fashion accessories, offering products such as watches, jewelry, handbags, small leather goods, belts, and sunglasses. It designs, develops, markets, and distributes products under its owned brands FOSSIL, SKAGEN, MICHELE, RELIC, and ZODIAC. It operates through Americas, Europe, and Asia segments, each including sales to wholesale and distributor customers, as well as Company-owned retail stores and e-commerce activities based on the location of the selling entity. The Americas segment contributes the majority of revenue and includes sales across Canada, Latin America, and the United States, while the Europe and Asia segments cover their respective regions. Each segment provides similar products and services.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: